Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-0037-2025

The EPIONE device v1.0.2 is a user controlled, stereotactic accessory device intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures. During the planning phase, the desired instrument placement and performance is defined relative to the target anatomy. During the guidance phase, the device enables to monitor respiratory levels and verify patient position prior to instrument advancement. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data.

Publicado el 16 de octubre de 2024 · Inicio del retiro: 5 de agosto de 2024

Resumen

FDA registra el retiro Z-0037-2025 de dispositivos médicos de Clase II, publicado el 16 de octubre de 2024 e iniciado el 5 de agosto de 2024. Empresa responsable: QUANTUM SURGICAL SAS; Estado: Completado; Cantidad reportada: 2 units; Lote: UDI/DI 37603054002NGXL, serial numbers: 0321015 and 0321017. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Completed — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Quantum Surgical has become aware that a component (central axis) inside the Needle Guide product (product number 02-0027) is the subject of rust.

Qué hacer

Voluntary: Firm initiated · Visit

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
QUANTUM SURGICAL SAS
Distribuidor
US Nationwide distribution in the state of FL.
Lote
UDI/DI 37603054002NGXL, serial numbers: 0321015 and 0321017
Clasificación de riesgo
Class II
Área (FDA)
device
País
France

Retiros relacionados

Preguntas sobre este retiro

¿The EPIONE device v1.0.2 is a user controlled, stereotactic accessory device intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures. During the planning phase, the desired instrument placement and performance is defined relative to the target anatomy. During the guidance phase, the device enables to monitor respiratory levels and verify patient position prior to instrument advancement. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data. fue retirado del mercado?

Sí. FDA publicó el retiro Z-0037-2025 el 16 de octubre de 2024. Peligro reportado: Quantum Surgical has become aware that a component (central axis) inside the Needle Guide product (product number 02-0027) is the subject of rust.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Visit